RS Investment Management’s AtriCure ATRC Stock Holding History

RS Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$28.7M	Sell	2,027,852 -155,845	-7%	-$2.38M	0.29%	125
2016 Q1	$36.8M	Sell	2,183,697 -495,854	-19%	-$8.72M	0.36%	104
2015 Q4	$60.1M	Buy	2,679,551 +466,200	+21%	+$9.61M	0.54%	62
2015 Q3	$48.5M	Buy	2,213,351 +503,141	+29%	+$12.6M	0.43%	85
2015 Q2	$42.1M	Buy	1,710,210 +535,380	+46%	+$12M	0.36%	100
2015 Q1	$24.1M	Buy	1,174,830 +120,592	+11%	+$2.34M	0.21%	167
2014 Q4	$21M	Buy	1,054,238 +191,500	+22%	+$3.29M	0.19%	184
2014 Q3	$12.7M	Buy	862,738 +19,100	+2%	+$304K	0.12%	217
2014 Q2	$15.5M	Buy	843,638 +233,138	+38%	+$3.88M	0.13%	202
2014 Q1	$11.5M	Buy	+610,500	New	+$12.5M	0.07%	223

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

RS Investment Management's ATRC Position: Q2 2016 in Review

RS Investment Management reduced its AtriCure (ATRC) stake by 7.1% in Q2 2016, selling an estimated $2.38M and leaving 2,027,852 shares worth $28.7M. The position accounts for 0.29% of the portfolio, ranked #125.

RS Investment Management first reported a position in ATRC in Q1 2014 and has held it in 10 quarters since. The position peaked at $60.1M in Q4 2015. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

RS Investment Management held 2,027,852 shares of AtriCure worth $28.7M as of Q2 2016.
RS Investment Management sold 155,845 AtriCure shares in Q2 2016, an estimated $2.38M.
AtriCure made up 0.29% of RS Investment Management's portfolio in Q2 2016, its #125 holding.
RS Investment Management first reported a position in AtriCure in Q1 2014 and has held it in 10 quarters since.
RS Investment Management's AtriCure position peaked at $60.1M in Q4 2015.
102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.